HA
HHLR Advisors Portfolio holdings
AUM
$3.1B
This Quarter Return
+32.35%
1 Year Return
+44.54%
3 Year Return
+121.93%
5 Year Return
+166.86%
10 Year Return
–
AUM
$13.2B
AUM Growth
+$13.2B
(+21%)
Cap. Flow
-$325M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
73.1%
Holding
94
New
20
Increased
11
Reduced
12
Closed
5
Top Buys
| 1 |
JD.com
JD
|
$636M |
| 2 |
KE Holdings
BEKE
|
$307M |
| 3 |
GDS Holdings
GDS
|
$252M |
| 4 |
Snowflake
SNOW
|
$105M |
| 5 |
IMAB
I-MAB
IMAB
|
$70.4M |
Top Sells
| 1 |
Zoom
ZM
|
$867M |
| 2 |
TAL Education Group
TAL
|
$288M |
| 3 |
Bilibili
BILI
|
$211M |
| 4 |
iQIYI
IQ
|
$167M |
| 5 |
Tesla
TSLA
|
$141M |
Sector Composition
| 1 | Technology | 28.22% |
| 2 | Consumer Discretionary | 25.68% |
| 3 | Healthcare | 25.64% |
| 4 | Communication Services | 8.49% |
| 5 | Consumer Staples | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zoom
ZM
$24.4B
| $2.36B | 17.85% | 5,012,049 -1,844,931 | -27% | -$867M |
|
|
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.57B | 11.87% | 5,472,259 | – | – |
|
|
3
JD.com
JD
$44.1B
| $1.24B | 9.41% | 16,005,041 +8,194,639 | +105% | +$636M |
|
4
Alibaba
BABA
$322B
| $1.19B | 9% | 4,042,123 +112,037 | +3% | +$32.9M |
|
|
5
iQIYI
IQ
$2.55B
| $887M | 6.72% | 39,302,362 -7,392,267 | -16% | -$167M |
|
6
Pinduoduo
PDD
$171B
| $757M | 5.73% | 10,206,116 +342,250 | +3% | +$25.4M |
|
7
Uber
UBER
$196B
| $703M | 5.32% | 19,260,700 | – | – |
|
|
CBPO
8
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $329M | 2.49% | 2,962,076 | – | – |
|
|
9
TAL Education Group
TAL
$6.46B
| $313M | 2.37% | 4,118,862 -3,787,179 | -48% | -$288M |
|
|
10
KE Holdings
BEKE
$20.8B
| $307M | 2.32% | +5,000,000 | New | +$307M |
|
|
ESGR
11
DELISTED
Enstar Group
ESGR
| $282M | 2.14% | 1,747,840 | – | – |
|
|
12
GDS Holdings
GDS
$6.62B
| $257M | 1.95% | 3,143,623 +3,076,923 | +4,613% | +$252M |
|
13
Salesforce
CRM
$245B
| $248M | 1.88% | 988,295 +278,800 | +39% | +$70.1M |
|
14
BridgeBio Pharma
BBIO
$9.89B
| $177M | 1.34% | 4,711,604 | – | – |
|
|
15
Bilibili
BILI
$9.6B
| $168M | 1.27% | 4,035,035 -5,067,028 | -56% | -$211M |
|
16
FibroGen
FGEN
$47.8M
| $163M | 1.23% | 3,955,787 | – | – |
|
17
Apellis Pharmaceuticals
APLS
$3.48B
| $152M | 1.15% | 5,028,289 | – | – |
|
18
Align Technology
ALGN
$10.3B
| $129M | 0.98% | 395,183 -395,182 | -50% | -$129M |
|
19
Mondelez International
MDLZ
$79.5B
| $128M | 0.97% | 2,225,264 -205,900 | -8% | -$11.8M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $127M | 0.96% | 1,364,631 | – | – |
|
21
argenx
ARGX
$43.6B
| $123M | 0.93% | 470,000 | – | – |
|
|
22
Snowflake
SNOW
$79.6B
| $105M | 0.8% | +420,000 | New | +$105M |
|
23
ZTO Express
ZTO
$14.6B
| $100M | 0.76% | 3,345,475 -88,117 | -3% | -$2.64M |
|
|
MYOK
24
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $94.2M | 0.71% | 690,658 | – | – |
|
25
Gossamer Bio
GOSS
$562M
| $92.1M | 0.7% | 7,420,974 | – | – |
|